1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Benign Prostatic Hyperplasia Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
2.2.1 Ongoing Benign Prostatic Hyperplasia Clinical Trials by Region
2.2.2 Average Enrollment of Benign Prostatic Hyperplasia Clinical Trials
2.2.3 Companies participating in Ongoing Trials
2.2.4 Drugs under Study for Benign Prostatic Hyperplasia Treatment, 2019

3. Region wise Benign Prostatic Hyperplasia Clinical Trials
3.1 Asia Pacific Benign Prostatic Hyperplasia Clinical Trials by Country
3.2 Europe Benign Prostatic Hyperplasia Clinical Trials by Country
3.3 North America Benign Prostatic Hyperplasia Clinical Trials by Country
3.4 Middle East and Africa Benign Prostatic Hyperplasia Clinical Trials by Country
3.5 South and Central America Benign Prostatic Hyperplasia Clinical Trials by Country

4. Benign Prostatic Hyperplasia Clinical Trial Trends
4.1 Start Year wise Ongoing Benign Prostatic Hyperplasia Clinical Trials
4.2 Phase wise Ongoing Benign Prostatic Hyperplasia Clinical Trials
4.3 Trial Status wise Ongoing Benign Prostatic Hyperplasia Clinical Trials
4.4 Trial Type wise Ongoing Benign Prostatic Hyperplasia Clinical Trials

5. Benign Prostatic Hyperplasia Average Enrollment Trends
5.1 Average Enrollment in Benign Prostatic Hyperplasia Trials by Year
5.2 Average Enrollment in Benign Prostatic Hyperplasia Trials by Phase
5.3 Average Enrollment in Benign Prostatic Hyperplasia Trials by Status
5.4 Average Enrollment in Benign Prostatic Hyperplasia Trials by Type of Trial

6. Companies Participating in Ongoing Benign Prostatic Hyperplasia Clinical Trials
6.1 Ongoing Benign Prostatic Hyperplasia Trials by Sponsor Type
6.2 Benign Prostatic Hyperplasia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ongoing Benign Prostatic Hyperplasia Trials- Phase 1
7.2 Ongoing Benign Prostatic Hyperplasia Trials- Phase 2
7.3 Ongoing Benign Prostatic Hyperplasia Trials- Phase 3
7.4 Ongoing Benign Prostatic Hyperplasia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Figure 9: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Phase
Figure 10: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Trial Status
Figure 11: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Type
Figure 12: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Sponsor Type
Figure 13: Benign Prostatic Hyperplasia Ongoing Clinical Trials by Leading Sponsors
Figure 14: Benign Prostatic Hyperplasia Average Enrollment by Phase
Figure 15: Benign Prostatic Hyperplasia Average Enrollment by Trial Status
Figure 16: Benign Prostatic Hyperplasia Average Enrollment by Type
Figure 17: Benign Prostatic Hyperplasia- Average Enrolment by Type of Sponsors
Figure 18: Benign Prostatic Hyperplasia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Benign Prostatic Hyperplasia Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Benign Prostatic Hyperplasia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Benign Prostatic Hyperplasia Average Enrollment by Phase
Table 15: Benign Prostatic Hyperplasia Average Enrollment by Trial Status
Table 16: Benign Prostatic Hyperplasia Average Enrollment by Type
Table 17: Benign Prostatic Hyperplasia- Average Enrolment by Type of Sponsors
Table 18: Benign Prostatic Hyperplasia- Enrolment by Leading Sponsors